Tamoxifen Citrate
Inquiry
| Post Date: | Mar 20,2019 |
| Expiry Date: | Mar 19,2020 |
| Detailed Description: |
Cas No. :54965-24-1
Quantity: 0.01Kilograms Specs:Foil Bag or Tin Price:1 USD Kilograms Payment Method: Western Union, MoneyGram, T/T Tamoxifen Citrate (Tamoxifen ,Nolvadex） Chemical Name: (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxyl]-N,N-dimethyl-ethanamine-citrate; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate Molecular Formula: C26H29NO.C6H8O7 Molecular weight: 563.64 CAS: 54965-24-1 EINECS: 259-415-2 Assay: 99%-101%. MF: C32H37NO8 Character: White crystalline powder. Usage: For the treatment of advanced, recurrent breast cancer and ovarian cancer and other illnesses. Used as an antineoplastic raw materials. Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30. Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two molecules are also very similar in structure. It is not correct that Nolvadex reduces levels of estrogen: rather, it blocks estrogen from estrogen receptors and, in those tissues where it is an antagonist, causes the receptor to do nothing. The claim that Nolvadex reduces gains should not be taken too seriously. The fact is that any number of bodybuilders have made excellent gains while using Nolvadex. The belief that it reduces gains seems to stem from the fact that the scientific literature reports a slight reduction in IGF-1 (individuals using anabolic steroids were not studied though) from use of Nolvadex Applications: Nolvadex is not an anabolic steroid but is used to manage side effects from steroids. |
| CAS Registry Number: | 54965-24-1 |
| Synonyms: | ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); |
| Molecular Formula: | C32H34NO8 |
| Molecular Weight: | 560.6159 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:Toxic; |
| Risk Codes: | R22:; R45:; |
| Safety Description: | S45:; S53:; |
| Company: | Zhuzhou Yuancheng Hezhong Technology Development Co., Ltd. |
| Contact: | Amy |
| Tel: | 0731-22222700 |
| Fax: | 0731-22222700 |
| Email: | ychz2016@chembj.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
